Why has the NHS granted reimbursement for the FreeStyle Libre 2 system?

"The FreeStyle Libre 2 flash glucose monitoring system is designed to change how people with diabetes measure their glucose levels and ultimately help them achieve better health outcomes. It is a revolutionary product for the UK diabetes community with strong support across patient groups, healthcare professionals and key opinion leaders.
Two clinical trialsi,ii and real‐world evidence from more than 50,000 usersiii show that people who use the FreeStyle Libre system scan their glucose levels an average of at least 15 times per day. In real‐world use, higher rates of scanning to self‐monitor glucose were found to be strongly associated with improved glucose measures, including decreased time in hypoglycaemia (low glucose levels) and hyperglycaemia (high glucose levels) and reduced estimated HbA1c.

i Bolinder J, Antuna R, Geelhoed‐Duijvestijn P, Kroger J, Weitgasser R. Novel glucose‐sensing technology and hypoglycaemia in Type 1 diabetes: a multicentre, non‐masked, randomised controlled trial [published online September 12, 2016]. Lancet. 2016;
ii Haak T, Hanaire H, Ajjan R et al. Flash glucose‐sensing technology as a replacement for blood glucose monitoring for the management of insulin‐treated Type 2 diabetes: a multicenter, open‐label randomized controlled trial. Diabetes Ther. 2017; 8: 55‐73
iii Dunn, T., Xu, Y., & Hayter, G. (2017). Evidence of a Strong Association Between Frequency of Flash Glucose Monitoring and Glucose Control Measures During Real‐World Usage. Diabetes Technology and Therapeutics, 19(S1). Doi: 10.1D89/dia.2017.2525.abstracts "